Request Trial
biohub-pic-for-lsip-
Photo: Birmingham BioHub
5 June 2016Biotechnology

Biotech in Birmingham: Alta Innovations’ story

Clustered around the imposing 1930s façade of the Queen Elizabeth Hospital in Birmingham is one of Britain’s fastest growing concentrations of biomedical companies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Merck KGaA agrees $11.3bn deal in major life sciences expansion
26 June 2026   Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of advanced research and analytical technologies.
Biotechnology
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026   Novartis will work with a US biotech company on new cancer therapies, while Lilly has partnered with a Chinese biopharma firm to develop new medicines.
Biotechnology
Insilico lands potential $2.5bn AI biotech partnership
22 June 2026   The partnership, announced at BIO 2026, marks the largest Asia-Pacific partnership by potential value that the AI-driven drug discovery company has secured to date.


Editor's picks

Novartis and Eli Lilly sign separate $1.9bn novel drug deals
Biotechnology
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026

Editor's picks

Biotechnology
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026
Big Pharma
US life sciences damages averaged $33.5m between 2019-2025
18 June 2026
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026

More features

Merck KGaA agrees $11.3bn deal in major life sciences expansion
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
Novo secures website blocking to tackle fake weight-loss drugs
Insilico lands potential $2.5bn AI biotech partnership
UPC hands Occlutech second win against Chinese medtech company in a month
US life sciences damages averaged $33.5m between 2019-2025
Quantum and photonics tech licensing expert joins EIP
Court upholds $83m sequencing verdict and sets royalty rate